RIFAMPICIN
-
Rifampicin drug used in TB treatment is expected to be commissioned later this year
The drug Rifampicin, which is used in serious bacterial infections, particularly Tuberculosis, is expected to be commissioned this year.
-
Tuberculosis deaths rising again in Europe: WHO
-
Redcliffe Labs launches diagnostic test to detect MDR-TB
-
Molbio launches Truenat MTB-INH test for drug resistance in TB patients
-
Around 5.4 lakh TB cases went unreported in India in 2018: WHO
-
Punjab installs 29 high-end machines for TB testing
-
Transporter, pharma company booked for cheating
-
IIT-Bombay study gives hope to resistant-TB patients
-
'UP beats national avg in drug-resistance TB cases'
Advertisement
Advertisement
Get updates on your preferred social platform
Follow us for the latest news, insider access to events and more.
